Coronavirus vaccinations begin in Hokkaido

Deputy director of Kushiro Rosai Hospital, Miyagishima Takuto receives his vaccination. February 19 at 2:30 p.m., Kushiro
Vaccines arrive Hokkaido Chuo Rosai Hospital. February 19 at midday, Iwamizawa

 Coronavirus vaccination of healthcare workers began in Hokkaido on February 19. Deliveries of the American-made Pfizer vaccine began in the morning, at 7 target medical facilities.

As well as the installation of ultra-low-temperature freezers on the 5th, to store the vaccines at each facility, adjustment of applications for vaccinations and the preparation of venues has also progressed, preventing any major confusion. The first vaccinations provide the chance to confirm not only the safety of the vaccine, but also the system and processes necessary for the full-scale vaccination of Hokkaido residents.

At the Hakodate National Hospital (Hakodate), where some of Hokkaido’s first vaccinations took place, injections were carried out in a meeting room. A post-vaccination waiting room with 30 numbered chairs placed 1 or 2 meters apart, and a temporary bed, was also prepared in case of any sudden changes in the physical condition of recipients.

 With regard to any reactions to the injection, hospital director, Kato Mototsugu said “Maybe some people will experience some sort of a reaction, but measures have been taken so there shouldn’t be any problems.” Vaccinations also continued over the weekend, and the second jabs are also expected to be completed by the end of March.

 Otsuka Yoshinori, director of the Hokkaido Chuo Rosai Hospital (Iwamizawa), where 300 people are scheduled to be vaccinated, received his jab along with 23 other colleagues there.

 Vaccination of staff members began at Kushiro Rosai Hospital (Kushiro), with 2 doctors, 3 nurses and 1 pharmacist receiving their jabs there. According to the hospital’s deputy director, Miyagishima Takuto, who is managing the vaccination spearhead, “It didn’t hurt much. The vaccine is highly effective. In order to achieve herd immunity, we need to vaccinate as many people as possible.”